Subcellular localization of dihydropyrimidine dehydrogenase

Biological Chemistry

Volumn 378, Issue 9, 1997, Pages 1047-1053

  Van Kuilenburg, André B P ^a   Van Lenthe, Henk ^a   Wanders, Ronald J A ^a   Van Gennip, Albert H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

5 Fluorouracil; Dihydropyrimidinase; Ureidopropionase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL ORGANELLE; CELLULAR DISTRIBUTION; CENTRIFUGATION; CYTOSOL; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVITY; LIVER HOMOGENATE; LIVER MITOCHONDRION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

EID: 0030881293     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1997.378.9.1047     Document Type: Article

References (40)

1. Antonenkov, V.D. (1989). Dehydrogenases of the pentose phosphate pathway in rat liver peroxisomes. Eur. J. Biochem. 183, 75-82.
2. Beuzeboc, P., Pierga, J.-Y., Stoppa-Lyonnet, D., Etienne, M.C., Milano, G., and Pouillart, P. (1996). Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta. Eur. J. Cancer 32A, 370-371.
3. Chance, B., Sies, H., and Boveris, A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-604.
4. Daher, G.C., Naguib, F.N.M., el Kouni, M.H., Zhang, R., Soong, S.J., and Diasio, R.B. (1991). Inhibition of fluoropyrimidine catabolism by benzyloxybenzyluracil. Biochem. Pharmacol. 41, 1887-1893.
5. De Duve, C., Pressman, B.C., Gianetto, R., Wattiaux, R., and Appelmans, F. (1955).Tissue fractionation studies. Biochem. J. 60, 604-617.
6. Diasio, R.B., Beavers, T.L., and Carpenter, J.T. (1988). Familial deficiency of dihydropyrimidine dehydrogenase, biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J. Clin. Invest. 81, 47-51.
7. Fleming, R.A., Milano, G.A., Gaspard, M.H., Bargnoux, P.J., Thyss, A., Plagne, R., Renée, M., Schneider, M., and Dermard, F. (1993). Dihydropyrimidine dehydrogenase activity in cancer patients. Eur. J. Cancer 29A, 740-744.
8. Hallock, R.O., and Yamada, E.W. (1976). Pyrimidine reducing enzymes of rat liver. Can. J. Biochem. 54, 178-184.
9. Harris, B.E., Carpenter, J.T., and Diasio, R.B. (1991). Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. Cancer 68, 499-501.
10. Heggie, G.D., Sommadossi, J.-P., Cross, D.S., Huster, W.J., and Diasio, R.B. (1987). Clinical pharmacokinetics of 5-fluorouracil and its metabolism in plasma, urine, and bile. Cancer Res. 47, 2203-2206.
11. Ho, D.H., Townsend, L., Luna, M.A., and Bodey, G.P. (1986). Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res. 6, 781-784.
12. Houyau, P., Gay, C., Chatelut, E., Canal, P., Roché, H., and Milano, G. (1993). Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency. J. Natl. Cancer Inst. 85, 1602-1603.
13. Iigo, M., Araki, E., Nakajima, Y., Hoshi, A., and De Clercq, E. (1988). Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice. Biochem. Pharmacol. 37, 1609-1613.
14. Kikugawa, M., Kaneko, M., Fujimoto-Sakata, S., Maeda, M., Kawasaki, K., Takagi, T., and Tamaki, N. (1994). Purification, characterization and inhibition of dihydropyrimidinase from rat liver. Eur. J. Biochem. 219, 393-399.
15. Lu, Z.-H., Zhang, R., and Diasio, R.B. (1992). Purification and characterization of dihydropyrimidine dehydrogenase from Human Liver. J. Biol. Chem. 267, 17102-17109.
16. Lu, Z., Zhang, R., and Diasio, R.B. (1993a). Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: Population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy. Cancer Res. 53, 5433-5438.
17. Lu, Z.-H., Zhang, R., and Diasio, R.B. (1993b). Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver. Biochem. Pharmacol. 46, 945-952.
18. Lyss, A.P., Lilenbaum, R.C., Harris, B.E., and Diasio, R.B. (1993). Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity. Cancer Invest. 11, 239-240.
19. Matthews, M.M., Liao, W., Kvalness-Krick, K.L., and Traut, T.W. (1992). β-Alanine synthase: purification and allosteric properties. Arch. Biochem. Biophys. 293, 254-263.
20. McGroarty, E., Hsieh, B., Wied, D.M., Gee, R., and Tolbert, N.E. (1974). Alpha hydroxy acid oxidation by peroxisomes. Arch. Biochem. Biophys. 161, 194-210.
21. Naguib, F.N.M., el Kouni, M.H., and Cha, S. (1985). Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res. 45, 5405-5412.
22. Podschun, B., Wahler, G., and Schnackerz, K.D. (1989). Purification and characterization of dihydropyrimidine dehydrogenase from pig liver. Eur. J. Biochem. 185, 219-224.
23. Shiotani, T., and Weber, G. (1981). Purification and properties of dihydrothymine dehydrogenase from rat liver. J. Biol. Chem. 256, 219-224.
24. Smith, A.E., and Yamada, E.W. (1971). Dihydrouracil dehydrogenase of rat liver. Separation of hydrogenase and dehydrogenase activities. J. Biol. Chem. 246, 3610-3617.
25. Spector, T., Harrington, J.A., and Porter, D.J.T. (1993). 5-Ethynyluracil (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo. Biochem. Pharmacol. 46, 2243-2248.
26. Stéphan, F., Etienne, M.C., Wallays, C., Milano, G., and Clergue, F. (1995). Depressed hepatic dihydropyrimidine dehydrogenase activity and fluorouracil-related toxicities. Am. J. Med. 99, 685-688.
27. Traut, T.W., and Loechel, S. (1984). Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay. Biochemistry 23, 2533-2539.
28. Tuchman, M., Stoeckeler, J.S., Kiang, D.T., O'Dea, R.F., Ramnaraine, M.L., and Mirkin, B.L. (1985). Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. New Engl. J. Med. 313, 245-249.
29. Vandor, S.L., and Tolbert, N.E. (1970). Glyoxylate metabolism by isolated rat liver peroxisomes. Biochim. Biophys. Acta 215, 449-455.
30. Van Gennip, A.M., Abeling, N.G.G.M., Stroomer, A.E.M., Van Lenthe, H., and Bakker, H.D. (1994). Clinical and biochemical findings in six patients with pyrimidine degradation defects. J. Inher. Metab. Dis. 17, 130-132.
31. Van Kuilenburg, A.B.P., Van Lenthe, H., and Van Gennip, A.H. (1996). Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man. Anticancer Res. 16, 389-394.
32. Van Kuilenburg, A.B.P., Vreken, P., Beex, L.V.A.M., Meinsma, R., Van Lenthe, H., De Abreu, R.A., and Van Gennip, A.H. (1997a) Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase ande severe 5-fluorouracil related toxicity. Eur. J. Cancer, in press.
33. Van Kuilenburg, A.B.P., Blom, M.J., Van Lenthe, H., Mul, E., and Van Gennip, A.H. (1997b). The activity of dihydropyrimidine dehydrogenase in human blood cells. J. Inher. Metab. Dis., in press.
34. Van Roermund, C.W.T., Van den Berg, M., and Wanders, R.J.A. (1995). Localization of peroxisomal 3-oxoacyl-CoA thiolase in particles of varied density in rat liver: implications for peroxisome biogenesis. Biochim. Biophys. Acta 1245, 348-358.
35. Völkl, A., and Fahimi, H.D. (1985). Isolation and characterization of peroxisomes from the rat liver of normal untreated rats. Eur. J. Biochem. 149, 257-265.
36. Vreken, P., Van Kuilenburg, A.B.P., Meinsma, R., Smit, G.P.A., Bakker, H.D., De Abreu, R.A., and Van Gennip, A.H. (1996). A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J. Inher. Metab. Dis. 19, 645-654.
37. Wanders, R.J.A., Van Roermund, C.W.T., De Vries, C.T., Van den Bosch, H., Schrakamp, G., Tager, J.M., Schram, A.W., and Schutgens, R.B.H. (1986). Peroxisomal β-oxidation of palmitoyl-CoA in human liver homogenates and its deficiency in the cerebro-hepato-renal (Zellweger) syndrome. Clin. Chim. Acta 159, 1-10.
38. Wanders, R.J.A., Van Roermund, C.W.T., Griffioen, M., and Cohen, L. (1991). Peroxisomal enzyme activities in the human hepatoblastoma cell line HepG2 as compared to human liver. Biochim. Biophys. Acta 1115, 54-59.
39. Wanders, R.J.A., Romeyn, G.J., Schutgens, R.B.H., and Tager, J.M. (1989). L-pipecolate oxidase: A distinct peroxisomal enzyme in man. Biochem. Biophys. Res. Commun. 164, 550-555.
40. Wei, X., McLeod, H.L., McMurrough J., Gonzalez, F.J. and Fernandez-Salguero, R (1996). Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J. Clin. Invest. 98, 610-615.